News Report | September 21, 2021
Otsuka Collaborating With Holmusk To Build A Digital Global Behavioral Health Platform
Otsuka Pharmaceutical Development & Commercialization, Inc. is collaborating with Holmusk to build a digital health platform for global behavioral health programs. The goal is to build a platform of real-world evidence supporting behavioral health outcomes. The two organizations have an existing relationship that started in 2020. On July 6, 2021, they signed a three-year collaboration agreement. Financial terms of the agreement have not been disclosed.
The platform is called NeuroBlu. It is an artificial intelligence (AI)-powered analytics platform that enables users to access one of the largest real-world clinical datasets in behavioral health. It is intended . . .